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Abstract
Background/Aims: Renal tissue fibrosis contributes to the development of end-stage renal 
disease. Causes for renal tissue fibrosis include obstructive nephropathy. The development of 
renal fibrosis following unilateral ureteral obstruction (UUO) is blunted in gene-targeted mice 
lacking functional serum- and glucocorticoid-inducible kinase SGK1. Similar to Akt isoforms, 
SGK1 phosphorylates and thus inactivates glycogen synthase kinase GSK-3. The present study 
explored whether PKB/SGK-dependent phoshorylation of GSK-3α/β impacts on pro-fibrotic 
signaling following UUO. Methods: UUO was induced in mice carrying a PKB/SGK-resistant GSK-
3α/β (gsk-3KI) and corresponding wild-type mice (gsk-3WT). Three days after the obstructive 
injury, expression of fibrosis markers in kidney tissues was analyzed by quantitative RT-PCR 
and western blotting. Results: GSK-3α and GSK-3β phosphorylation was absent in both, the 
non-obstructed and the obstructed kidney tissues from gsk-3KI mice but was increased by UUO 
in kidney tissues from gsk-3WT mice. Expression of α-smooth muscle actin, type I collagen and 
type III collagen in the non-obstructed kidney tissues was not significantly different between 
gsk-3KI mice and gsk-3WT mice but was significantly less increased in the obstructed kidney 
tissues from gsk-3KI mice than from gsk-3WT mice. After UUO treatment, renal ß-catenin protein 
abundance and renal expression of the ß-catenin sensitive genes: c-Myc, Dkk1, Twist and 
Lef1 were again significantly less increased in kidney tissues from gsk-3KI mice than from gsk-
3WT mice. Conclusions: PKB/SGK-dependent phosphorylation of glycogen synthase kinase 
GSK-3 contributes to the pro-fibrotic signaling leading to renal tissue fibrosis in obstructive 
nephropathy.
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Introduction
Renal tissue fibrosis is a major pathophysiological mechanism leading to end-stage renal 
failure in the course of diabetes, hypertension, renal ischemia and obstructive nephropathy 
[1, 2]. The renal pathology of chronic kidney disease is characterized by tubulo-interstitial 
fibrosis due to matrix deposition by myofibroblasts [3]. Myofibroblasts could originate 
from resident fibroblasts, bone-marrow-derived cells or from epithelial to mesynchymal 
transition (EMT), by which endothelial cells, glomerular podocytes and renal tubular cells 
transform into mesenchymal cells [3-5]. Myofibroblasts express mesenchymal cell products, 
such as α-smooth muscle actin (α-Sma) and collagen [6].
Renal fibrosis is a hallmark of chronic kidney disease, regardless of its initial cause 
[1, 2, 7]. The process of renal fibrosis involves various signaling pathways, most notably 
the transforming growth factor TGFß pathway [1, 2, 6]. TGFß is involved in renal fibrosis 
following obstructive injury, diabetic nephropathy and other renal diseases [2]. TGFß strongly 
stimulates the expression of serum- and glucocorticoid-inducible kinase SGK1, a kinase 
implicated in fibrosing disease [8]. As a matter of fact, SGK1 is required for full stimulation of 
renal tissue fibrosis following unilateral ureteral obstruction [6]. SGK1-dependent signaling 
includes phosphorylation and thus inhibition of the glycogen synthase kinase GSK-3 [9-11], 
which has in turn been implicated in the development of organ hypertrophy, fibrosis and 
EMT [6, 11-17]. GSK-3β is further phosphorylated by PKB, both of which are phosphorylated 
after unilateral ureteral obstruction [6, 18, 19]. In the unilateral ureteral obstruction (UUO) 
model, GSK-3 beta phosphorylation peaked 3 days after the onset of obstructive injury [6]. 
GSK-3β phosphorylation is an important early mechanism in the EMT of collecting duct cells 
[20]. 
Wnt/ ß-catenin activation is a key event in renal fibrosis following UUO, and inhibition 
of this pathway reduces myofibroblast activation and renal fibrosis [14, 21]. GSK-3 in its 
active state initiates the degradation of ß-catenin, thereby inhibiting its activity [22, 23]. Both 
PKB/SGK and Wnt signaling cascades modify GSK-3, yet via distinct mechanisms and with 
distinct downstream effects [24, 25]. A crosstalk of PKB with ß-catenin signaling via GSK-3 
has been suggested, but is still elusive [18, 26]. PKB/SGK-dependent phosphorylation of GSK-
3 can be disrupted by replacement of the serine within the PKB/SGK phosphorylation sites by 
alanine (GSK-3α21A/21A, GSK-3ß9A/9A) [18]. Gene-targeted mice carrying these mutations (gsk-
3KI) should thus be resistant to signaling requiring PKB/SGK-dependent phosphorylation of 
GSK-3α/β [18, 27].
In order to explore whether PKB/SGK-dependent phosphorylation of GSK-3α/β participates 
in the initiation of renal tissue fibrosis following obstructive nephropathy, the effects of short-




All animal experiments were conducted according to the German law for the welfare of animals and were 
approved by local authorities. Experiments have been performed in gene-targeted mice carrying a mutant 
GSK-3α/β, in which the codon encoding Ser9 of the GSK-3ß gene was changed to encode nonphosphorylatable 
alanine (GSK-3ß9A/9A), and simultaneously the codon encoding Ser21 of GSK-3α was changed to encode the 
nonphosphorylatable GSK-3α21A/21A thus yielding the GSK-3α/β21A/21A/9A/9A double knockin mouse (gsk-3KI) as 
described previously [18, 27]. The mice were compared to corresponding wild-type mice (gsk-3WT). 
Unilateral ureteral obstruction
Renal fibrosis was induced by unilateral ureteral obstruction (UUO) [28, 29]. Following surgical 
incision of the skin and peritoneum, the left ureter was exposed and ligated twice with a non-resorbable 7-0 
filament. Following ligation the surgical wound was closed by sutures. Mice were treated with metamizole 
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for analgesia (200 mg/kg BW) after the procedure and for the duration of the UUO experiment in drinking 
water. The mice were sacrificed 3 days after the ligation procedure and the obstructed as well as the non-
ligated kidney rapidly removed and kidney tissues snap frozen in liquid nitrogen. 
Quantitative RT-PCR
Total RNA was isolated from murine kidney tissues using Trifast Reagent (Peqlab) according to the 
manufacturer’s instructions. Reverse transcription of 2 µg RNA was performed using oligo(dT)12-18 primers 
(Invitrogen) and SuperScript III Reverse Transcriptase (Invitrogen). Quantitative real-time PCR was 
performed with the iCycler iQTM Real-Time PCR Detection System (Bio-Rad Laboratories) and iQ Sybr Green 
Supermix (Bio-Rad Laboratories) according to the manufacturer’s instructions. The following primers were 
used (5’→3’ orientation): 
a-Sma fw: CCCAGACATCAGGGAGTAATGG; a-Sma rev: CTATCGGATACTTCAGCGTCA;
c-Myc fw: ATGCCCCTCAACGTGAACTTC; c-Myc rev: GTCGCAGATGAAATAGGGCTG;
Col1a1fw:ACCCGAGGTATGCTTGATCTG; Col1a1rev:CATTGCACGTCATCGCACAC;
Col3a1fw:CCATTTGGAGAATGTTGTGCAAT; Col3a1rev:GGACATGATTCACAGATTCCAGG;
Dkk1 fw: CAATTCCAACGCGATCAAGAAC; Dkk1 rev: CCGCCCTCATAGAGAACTCC;
Gapdh fw: AGGTCGGTGTGAACGGATTTG; Gapdh rev: TGTAGACCATGTAGTTGAGGTCA; 
Lef1 fw: TGTTTATCCCATCACGGGTGG; Lef1 rev: CATGGAAGTGTCGCCTGACAG;
Twist fw: GGACAAGCTGAGCAAGATTCA; Twist rev: CGGAGAAGGCGTAGCTGAG.
The specificity of the PCR products was confirmed by analysis of the melting curves. All PCRs were 
performed in duplicate, and mRNA fold changes were calculated by the 2-ΔΔCt method using Gapdh as internal 
reference. Results are shown normalized to the mRNA expression in the obstructed kidney tissues of gsk-3WT 
mice.
Western blot analysis 
Murine kidney tissues were lysed with ice-cold lysis buffer (Thermo Fisher Scientific) supplemented 
with complete protease and phosphatase inhibitor cocktail (Thermo Fisher Scientific). After centrifugation 
at 10000 rpm for 5 min, proteins were boiled in Roti-Load1 Buffer (Carl Roth GmbH) at 100ºC for 10 min. 
Proteins were separated on SDS-polyacrylamide gels and transferred to PVDF membranes. The membranes 
were incubated overnight at 4°C with the following primary antibodies: rabbit anti-α-smooth muscle actin, 
rabbit anti-collagen I (used at a 1:1000 dilution, Abcam), rabbit anti-phospho GSK-3α/β (Ser21/9), rabbit 
anti-GSK-3α, rabbit anti-GSK-3β, rabbit anti-β-catenin, rabbit anti-GAPDH antibody (used at a 1:1000 
dilution, Cell Signaling) and then with secondary goat anti-rabbit HRP-conjugated antibody (diluted 
1:1000, Cell Signaling) for 1 hour at room temperature. For loading controls, the membranes were stripped 
with stripping buffer (Carl Roth GmbH) at 56°C for 5 min. Antibody binding was detected with the ECL 
detection reagent (Thermo Fisher Scientific). Bands were quantified with Quantity One Software (Bio-Rad 
Laboratories) and results are shown as the ratio of phosphorylated to total protein and as the ratio of total 
protein to Gapdh.
Statistics
Data are provided as means ± SEM, n represents the number of independent experiments. All data 
were tested for significance between genotypes using unpaired Student t-test (normally distributed data) 
or Mann-Whitney test (non-normally distributed data) according to Shapiro-Wilk test. Only results with p < 
0.05 were considered statistically significant.
Results
In a first series of experiments, a phospho-specific antibody for GSK-3α/β (Ser21/Ser9) 
was used to describe the difference in phosphorylation between gsk-3 knockin mice lacking 
functional PKB/SGK phosphorylation sites of GSK-3α/β (gsk-3KI) and their corresponding 
wild-type mice (gsk-3WT) in the non-obstructed contra-lateral kidney and in the obstructed 
kidney after a short term obstruction period (3 days). As illustrated in Fig. 1, only weak GSK-
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3α and GSK-3β phosphorylation was observed in the non-obstructed kidney tissues of wild-
type mice and no phosphorylation of GSK-3α and GSK-3β in renal tissues of gsk-3KI mice. Within 
three days of unilateral ureteral obstruction, strong GSK-3α and GSK-3ß phosphorylation was 
observed in renal tissues from gsk-3WT mice but not from gsk-3KI mice (Fig. 1B,D). In neither, the 
non-obstructed nor the obstructed kidney tissues, significant differences of total GSK-3α and 
GSK-3β protein abundance were observed between the genotypes (Fig. 1C,E).
To quantify the relevance of PKB/SGK-dependent phosphorylation of GSK-3α/β on the 
fibrotic response after UUO, the expression of renal α-smooth muscle actin was determined 
(Fig. 2). In the non-obstructed kidney tissues, mRNA levels and protein expression of α-smooth 
muscle actin were low and not significantly different between gsk-3KI and gsk-3WT mice.  Following 
UUO treatment, the α-smooth muscle actin mRNA and protein levels were significantly less 
increased in kidney tissues from gsk-3KI mice than in kidney tissues from gsk-3WT mice. 
To further elucidate whether PKB/SGK-dependent phosphorylation of GSK-3α/β 
participates in the signaling of renal tissue fibrosis following UUO, the expression of type I 
collagen and type III collagen was determined (Fig. 3). In non-obstructed kidney tissues, the 
protein abundance of collagen type I was not significantly different between gsk-3KI mice 
and gsk-3WT mice. Following UUO, the protein expression of collagen type I was significantly 
less increased in kidney tissues from gsk-3KI mice than in kidney tissues from gsk-3WT mice 
(Fig. 3A,B). Furthermore, in non-obstructed control kidneys the renal mRNA expression of 
Col1a1 and Col3a1 was low and not significantly different between gsk-3KI mice and gsk-3WT 
mice. Following obstructive injury, the renal mRNA levels of both, Col1a1 and Col3a1 were again 
significantly less increased in gsk-3KI mice than in gsk-3WT mice (Fig. 3C,D). 
Further experiments addressed the role of PKB/SGK-dependent phosphorylation of GSK-
3α/β on ß-catenin protein abundance in non-obstructed control kidney tissues or UUO treated 
kidney tissues from gsk-3KI mice and gsk-3WT mice. As illustrated in Fig. 4, ß-catenin protein 
expression was not significantly different between non-obstructed kidney tissues from gsk-3KI 
and gsk-3WT mice. Following UUO treatment, ß-catenin protein abundance was significantly less 
increased in renal tissues from gsk-3KI mice as compared to renal tissues from gsk-3WT mice.
Fig. 1. GSK-3 phosphorylation in renal tissues of gsk-3WT and gsk-3KI mice following unilateral ureteral obstruc-
tion. A. Representative original western blots showing GSK-3α/β phosphorylation at Ser21/9, total GSK-3α, 
total GSK-3β and Gapdh protein abundance in kidney tissues of gsk-3 knockin mice lacking functional PKB/
SGK phosphorylation sites in GSK-3α/β (gsk-3KI) and their corresponding wild-type mice (gsk-3WT) in non-ob-
structed control kidneys (CTR) and following unilateral ureteral obstruction (UUO). Arithmetic means ± SEM 
(n=6) of phosphorylated/total GSK-3α (B), total GSK-3α /Gapdh (C), phosphorylated/total GSK-3β (D) and total 
GSK-3β/Gapdh (E) protein ratio in kidney tissues of gsk-3 knockin mice lacking functional PKB/SGK phos-
phorylation sites in GSK-3α/β (gsk-3KI, closed bars) and their corresponding wild-type mice (gsk-3WT, open 
bars) in non-obstructed control kidneys (CTR) and following unilateral ureteral obstruction (UUO). *(p<0.05), 
**(p<0.01) indicates statistically significant differences from respective kidney tissues of gsk-3WT mice.
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Fig. 2. α-Smooth muscle actin expression in renal tissues of gsk-3WT and gsk-3KI mice following unilateral ure-
teral obstruction. A. Representative original western blots showing α-smooth muscle actin (α-Sma) and Gap-
dh protein abundance in kidney tissues of gsk-3 knockin mice lacking functional PKB/SGK phosphorylation 
sites in GSK-3α/β (gsk-3KI) and their corresponding wild-type mice (gsk-3WT) in non-obstructed control kidneys 
(CTR) and following unilateral ureteral obstruction (UUO). B. Arithmetic means ± SEM (n=6) of α-smooth mus-
cle actin/Gapdh protein ratio in kidney tissues of gsk-3 knockin mice lacking functional PKB/SGK phospho-
rylation sites in GSK-3α/β (gsk-3KI, closed bars) and their corresponding wild-type mice (gsk-3WT, open bars) in 
non-obstructed control kidneys (CTR) and following unilateral ureteral obstruction (UUO). C. Arithmetic means 
± SEM (n=7; arbitrary units) of α-smooth muscle actin (α-Sma) relative mRNA expression in kidney tissues of 
gsk-3 knockin mice lacking functional PKB/SGK phosphorylation sites in GSK-3α/β (gsk-3KI, closed bars) and 
their corresponding wild-type mice (gsk-3WT, open bars) in non-obstructed control kidneys (CTR) and following 
unilateral ureteral obstruction (UUO). *(p<0.05) indicates statistically significant differences from respective 
kidney tissues of gsk-3WT mice.
Fig. 3. Collagen expression in 
renal tissues of gsk-3WT and 
gsk-3KI mice following uni-
lateral ureteral obstruction. 
A. Representative original 
western blots showing colla-
gen type I and Gapdh protein 
abundance in kidney tissues 
of gsk-3 knockin mice lacking 
functional PKB/SGK phos-
phorylation sites in GSK-3α/β 
(gsk-3KI) and their correspond-
ing wild-type mice (gsk-3WT) 
in non-obstructed control 
kidneys (CTR) and following 
unilateral ureteral obstruction 
(UUO). B. Arithmetic means ± 
SEM (n=6) of collagen type I/
Gapdh protein ratio in kidney tissues of gsk-3 knockin mice lacking functional PKB/SGK phosphorylation 
sites in GSK-3α/β (gsk-3KI, closed bars) and their corresponding wild-type mice (gsk-3WT, open bars) in non-ob-
structed control kidneys (CTR) and following unilateral ureteral obstruction (UUO). Arithmetic means ± SEM 
(n=7; arbitrary units) of collagen type I (Col1a1, C) and collagen type III (Col3a1, D) relative mRNA expression in 
kidney tissues of gsk-3 knockin mice lacking functional PKB/SGK phosphorylation sites in GSK-3α/β (gsk-3KI, 
closed bars) and their corresponding wild-type mice (gsk-3WT, open bars) in non-obstructed control kidneys 
(CTR) and following unilateral ureteral obstruction (UUO). *(p<0.05), **(p<0.01) indicates statistically signif-
icant differences from respective kidney tissues of gsk-3WT mice.
In order to explore the functional significance of differences in ß-catenin protein 
abundance in gsk-3KI and gsk-3WT mice following obstructive injury, the transcript levels of 
ß-catenin sensitive genes [14]: c-Myc, Dickkopf 1 (Dkk1), Twist and lymphoid enhancer-
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binding factor 1 (Lef1) were determined. As shown in Fig. 5, in the non-obstructed kidney 
tissues, the renal expression of the genes encoding: c-Myc, Dkk1 and Lef1 were not significantly 
different between gsk-3KI and gsk-3WT mice. The mRNA expression of Twist was significantly 
lower in the non-obstructed kidney tissues of gsk-3KI mice as compared to non-obstructed 
kidney tissues from gsk-3WT mice. Following UUO treatment, the renal transcript levels of the 
ß-catenin target genes: c-Myc, Dkk1, Twist and Lef1 were significantly less increased in renal 
tissues from gsk-3KI mice than in renal tissues from gsk-3WT mice. 
  
Discussion 
The present study sheds new light on the signaling of renal fibrosis following obstructive 
nephropathy. Disruption of PKB and SGK1-dependent phosphorylation of glycogen synthase 
Fig. 4. ß-catenin protein 
abundance in renal tissues 
of gsk-3WT and gsk-3KI mice 
following unilateral ureteral 
obstruction. A. Representa-
tive original western blots 
showing ß-catenin and Gap-
dh protein abundance in kid-
ney tissues of gsk-3 knockin 
mice lacking functional 
PKB/SGK phosphorylation sites in GSK-3α/β (gsk-3KI) and their corresponding wild-type mice (gsk-3WT) in 
non-obstructed control kidneys (CTR) and following unilateral ureteral obstruction (UUO). B. Arithmetic means 
± SEM (n=6) of ß-catenin/Gapdh protein ratio in kidney tissues of gsk-3 knockin mice lacking functional PKB/
SGK phosphorylation sites in GSK-3α/β (gsk-3KI, closed bars) and their corresponding wild-type mice (gsk-
3WT, open bars) in non-obstructed control kidneys (CTR) and following unilateral ureteral obstruction (UUO). 
**(p<0.01) indicates statistically significant differences from respective kidney tissues of gsk-3WT mice.
Fig. 5. Expression of ß-catenin 
target genes in renal tissues of 
gsk-3WT and gsk-3KI mice fol-
lowing unilateral ureteral ob-
struction. Arithmetic means ± 
SEM (n=7; arbitrary units) of 
c-Myc (A), Dickkopf 1 (Dkk1, 
B), Twist (C) and lymphoid en-
hancer-binding factor 1 (Lef1, 
D) relative mRNA expression in 
kidney tissues of gsk-3 knockin 
mice lacking functional PKB/
SGK phosphorylation sites in 
GSK-3α/β (gsk-3KI, closed bars) 
and their corresponding wild-
type mice (gsk-3WT, open bars) in 
non-obstructed control kidneys 
(CTR) and following unilater-
al ureteral obstruction (UUO). 
*(p<0.05), **(p<0.01), ***(p<0.001) indicate statistically significant differences from respective kidney tis-
sues of gsk-3WT mice.
CTR UUO
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kinase GSK-3α/β significantly blunted the increase of collagen and α-smooth muscle actin 
expression following short term UUO. Furthermore, the renal ß-catenin protein abundance 
and transcript levels of the ß-catenin target genes: c-Myc, Dkk1, Twist and Lef1 following 
obstructive injury were significantly less increased in gsk-3KI mice than in gsk-3WT mice. 
Previous studies revealed the critical involvement of TGFß in the triggering of fibrosis of 
the kidney [2]. GSK-3 inactivation is an important mechanism in TGFß-induced senescence 
[30]. TGFß stimulates the expression of SGK1 [8], which in turn significantly contributes 
to the stimulation of renal fibrosis following unilateral ureteral obstruction [6]. SGK1 is 
presumably at least in part effective by phosphorylating glycogen synthase kinase GSK-3, 
a known target of both SGK and AKT isoforms [9-11]. Both, AKT and SGK1 are upregulated 
following renal obstruction leading to increased phosphorylation of GSK-3β [6, 19]. Ample 
evidence points to a significant role of GSK-3 in the regulation of fibroblast differentiation 
and tissue fibrosis [6, 11, 12, 14, 15]. In cardiac tissue, for instance, the remodelling and 
fibrosis following beta-adrenergic challenge was blunted in gsk-3KI mice [31].
A key signaling pathway promoting renal fibrosis is the Wnt/ß-catenin pathway [14, 
21]. Wnt signals through GSK-3 to stabilize ß-catenin, a signaling process distinct from 
PKB/SGK1 signaling [22, 23, 32]. The ß-catenin protein abundance is similarly low in 
non-obstructed kidneys of gsk-3KI and gsk-3WT mice, but the increase of ß-catenin protein 
abundance in obstructed kidneys was blunted in gsk-3KI mice as compared to gsk-3WT mice. 
Following UUO, inhibition of PKB/SGK1-dependent phosphorylation of GSK-3 thus impacts 
on the Wnt/ß-catenin signaling pathway. Akt-sensitive ß-catenin activity has been observed 
earlier [32, 33]. The effect of PKB/SGK1 signaling on ß-catenin is, however, not necessarily 
direct, but could be secondary to other mechanisms [32]. For example, PKB/SGK1 - GSK-3 
signaling regulates Snail, which fosters activation of ß-catenin and could thereby serve as 
the link between PI3K and Wnt/ß-catenin signalling [6, 16, 17, 20, 34]. In accordance with 
previous observations, PKB/SGK1-dependent GSK-3α/β phosphorylation is nonetheless an 
important event in renal fibrosis signaling [6, 20].
PKB/SGK is an important target for TGFβ in renal disease [8, 35]. At least in theory, PKB/
SGK-dependent phosphorylation of GSK-3α/β could similarly participate in the mechanisms 
triggering renal tissue fibrosis following other challenges, such as diabetes, hypertension 
and renal ischemia [1, 17, 20]. It is noteworthy that SGK1 is highly expressed in diabetic 
nephropathy [36] and kidney biopsies from proteinuric renal failure patients [37]. Moreover, 
SGK1 appears to be critically important for renal [38] and cardiac [15, 39, 40] fibrosis. 
Notably, mineralocorticoid-induced cardiac fibrosis was paralleled by enhanced GSK-3 
phosphorylation, which was, however, not dependent on SGK1 and may have at least in part 
been due to phosphorylation by PKB isoforms [11]. 
Conclusion
AKT and SGK1-dependent phosphorylation of glycogen synthase kinase GSK-3α/β 
participates in the signaling leading to renal tissue fibrosis and its disruption blunts the 
stimulation of fibrosis markers following unilateral ureteral obstruction. 
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